EP0692969A4 - Procede de traitement d'une maladie par la suppression des lymphocytes t - Google Patents

Procede de traitement d'une maladie par la suppression des lymphocytes t

Info

Publication number
EP0692969A4
EP0692969A4 EP94912969A EP94912969A EP0692969A4 EP 0692969 A4 EP0692969 A4 EP 0692969A4 EP 94912969 A EP94912969 A EP 94912969A EP 94912969 A EP94912969 A EP 94912969A EP 0692969 A4 EP0692969 A4 EP 0692969A4
Authority
EP
European Patent Office
Prior art keywords
deletion
diseases
cells
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94912969A
Other languages
German (de)
English (en)
Other versions
EP0692969A1 (fr
Inventor
Philippa Marrack
John Kappler
James E Mccormack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Jewish Health
Original Assignee
National Jewish Center for Immunology and Respiratory Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Jewish Center for Immunology and Respiratory Medicine filed Critical National Jewish Center for Immunology and Respiratory Medicine
Publication of EP0692969A1 publication Critical patent/EP0692969A1/fr
Publication of EP0692969A4 publication Critical patent/EP0692969A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP94912969A 1993-04-08 1994-04-08 Procede de traitement d'une maladie par la suppression des lymphocytes t Withdrawn EP0692969A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4549493A 1993-04-08 1993-04-08
US45494 1993-04-08
PCT/US1994/003861 WO1994023734A1 (fr) 1993-04-08 1994-04-08 Procede de traitement d'une maladie par la suppression des lymphocytes t

Publications (2)

Publication Number Publication Date
EP0692969A1 EP0692969A1 (fr) 1996-01-24
EP0692969A4 true EP0692969A4 (fr) 1997-08-20

Family

ID=21938212

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94912969A Withdrawn EP0692969A4 (fr) 1993-04-08 1994-04-08 Procede de traitement d'une maladie par la suppression des lymphocytes t

Country Status (5)

Country Link
EP (1) EP0692969A4 (fr)
JP (1) JPH08508752A (fr)
AU (1) AU6530794A (fr)
CA (1) CA2159891A1 (fr)
WO (1) WO1994023734A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012818A1 (fr) * 1990-02-23 1991-09-05 Immulogic Pharmaceutical Corporation Absence de faculte de reponse immune induite par superantigene

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012818A1 (fr) * 1990-02-23 1991-09-05 Immulogic Pharmaceutical Corporation Absence de faculte de reponse immune induite par superantigene

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE FILE SERVER STN KARLSRUHE; IGNATOWICZ ET AL: "THE EFFECTS OF CHRONIC INFECTION WITH A SUPERANTIGEN-PRODUCING VIRUS", XP002032543 *
JOURNAL OF EXPERIMENTAL MEDICINE, vol. 175, no. 4, 1 April 1992 (1992-04-01), pages 917 - 923 *
MCCORMACK ET AL: "PROFOUND DELETION OF MATURE T CELLS IN VIVO BY CHRONIC EXPOSURE TO EXOGENOUS SUPERANTIGEN", THE JOURNAL OF IMMUNOLOGY, vol. 150, no. 9, 1 May 1993 (1993-05-01), pages 3785 - 3792, XP002032542 *
See also references of WO9423734A1 *
ZALLER ET AL: "PREVENTION AND TREATMENT OF MURINE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITH T CELL RECEPTOR VBETA-SPECIFIC ANTIBODIES", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 171, 1990, pages 1943 - 1955, XP000674640 *

Also Published As

Publication number Publication date
WO1994023734A1 (fr) 1994-10-27
AU6530794A (en) 1994-11-08
CA2159891A1 (fr) 1994-10-27
JPH08508752A (ja) 1996-09-17
EP0692969A1 (fr) 1996-01-24

Similar Documents

Publication Publication Date Title
US5281607B1 (en) Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
IL106255A0 (en) Method for isolating human blood cells
GB9027968D0 (en) Method of treatment
AU7484791A (en) Method of treating diseases associated with elevated levels of interleukin 1
AU3730093A (en) Methods of treating diabetes
AU613355B2 (en) Method for treating skin diseases
GB9218027D0 (en) Novel method of treatment
EP0692969A4 (fr) Procede de traitement d'une maladie par la suppression des lymphocytes t
AU7120987A (en) Composition for and method of treating aids and certain related diseases
GB9202196D0 (en) Method of treatment
GB9226309D0 (en) Improved method of manufacture
AU8752991A (en) Method of treating auto-immune diseases using gallium compounds
GB9201391D0 (en) Method of treatment
GB9218597D0 (en) Novel method of treatment
AU665311C (en) Method of treatment of androgen-related diseases
GB9226371D0 (en) Novel method of treatment
GB9326020D0 (en) Novel method of treatment
GB9308853D0 (en) Novel method of treatment
GB9321796D0 (en) Method of treatment
GB9321971D0 (en) Method of treatment
GB9307004D0 (en) Method of treatment
GB9202020D0 (en) Method of treatment
GB9223252D0 (en) Method of treatment
GB9226252D0 (en) Method of treatment
GB9207275D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19970704

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19970818

R18W Application withdrawn (corrected)

Effective date: 19970814